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Abstract Chlordecone (Kepone) is an organochlorine insec-
ticide that has been used as insecticide and fungicide. In the
FrenchWest Indies, Guadeloupe and Martinique, it was inten-
sively applied to banana fields from 1973 to 1993 to control
root borers. This pesticide undergoes no significant biotic or
abiotic degradation in the environment and is still present in
soils where it was applied. It was only in 1999 that health and
environmental authorities became aware of the extent of the
chlordecone pollution of environmental media, including
soils, waterways, and the food chain. Earlier observations
and toxicological studies have demonstrated that chlordecone
is a reproductive and developmental toxicant, neurotoxic and
carcinogenic in rodents, and is an endocrine-disrupting chem-
ical because of its estrogenic properties both in vitro and
in vivo. Several surveys have confirmed that the French
West Indian population continues to be exposed to this chem-
ical though consumption of contaminated foodstuffs. Here,
we report the findings of various epidemiological studies con-
ducted in the French West Indies to assess the impact of envi-
ronmental exposure to chlordecone on the health of the
population.
Keywords Cancer . Chlordecone . Development . Endocrine
disruptor . Fertility . FrenchWest Indies . Insecticides .
Organochlorine . Pregnancy
Introduction
Chlordecone is an organochlorine insecticide that was used
intensively in the French West Indies, Guadeloupe and
Martinique, from 1973 to 1993 to control banana root borers.
As early as 1975, residual concentrations of this chemical
were reported in soils previously used to grow bananas and
subsequently converted to other agricultural activities, and in
river water bordering banana fields (Snegaroff 1977). In 1980,
a detailed report showed that chlordecone was the chlorinated
chemical most frequently detected and at the highest concen-
trations in wild birds, mammals, fish, and shellfish living in
areas of banana cultivation or at the coast near outlets of con-
taminated rivers (Cavelier 1980). Despite these warning sig-
nals, it was only from 1999 that French authorities and the
population became aware of the extent of the pollution of
environmental media. It was in 1999 that the implementation
of the Drinking Water Directive of the European Union in the
French West Indies revealed the presence of chlordecone at
high concentrations (up to 10 μg/L) in numerous water re-
sources. Later surveys conducted by environmental, health
and food authorities and regulatory agencies revealed that it
was extensively distributed in soils, rivers, spring and ground
waters, aquatic biota, and crops (DIREN 2001; DSDS 2001;
Dubuisson et al. 2007). These observations are not surprising
because both the degradation of chlordecone whether physi-
cochemical (abiotic) or microbial (biotic) is slow (Faroon et al.
1995). It has been estimated that the duration of chlordecone
pollution of soil in French West Indies will last for decades or
centuries (Cabidoche et al. 2009). Because a large proportion
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of tap water, local bottled spring water, and local foodstuffs
were polluted and these products have been consumed, it was
anticipated that human beings were also contaminated
(Dubuisson et al. 2007). This was a major concern for health
authorities and caused substantial anxiety in the population
about the potential health implications.
What we knew about chlordecone toxicity in 1999?
The toxicity and harmful effects of chlordecone exposure to
humans was revealed in 1975 following a poisoning episode
involving chlordecone plant workers in the industrial city of
Hopewell, VA, USA (Cannon et al. 1978). Male workers
showed evidence of prolonged toxicity involving the central
nervous system (mainly appendicular intentional tremors,
ataxia, oculomotor dysfunctions, slurred speech, irritability,
mood disorders, and recent memory loss), enlarged liver and
both low sperm cell counts and decreased percentages of mo-
tile sperm cells (Cannon et al. 1978; Cohn et al. 1978; Taylor
1982). These symptoms and clinical signs were grouped under
the term of Kepone shake syndrome and were observed in
subjects with chlordecone concentrations in blood over
1 mg/mL. The symptoms and clinical signs were reported to
be reversible for most workers after cessation of exposure, and
regression paralleled decreasing chlordecone concentrations
in blood (Cohn et al. 1978; Taylor. 1982). The estimated blood
half-life was estimated to be 120 to 160 days (Cohn et al.
1978). Detailed analysis of biological tissues and fluids
revealed that the highest concentration of chlordecone
was in the liver. Tissue-to-blood ratios (partition coefficient
expressed for wet weight conditions) for the liver, fat, muscle,
and gallbladder bile were 15, 6.7, 2.9, and 2.5, respectively
(Cohn et al. 1978). Partition coefficients from liver or fat to
blood (15 and 6.7, respectively) are lower than expected for a
highly lipophilic organochlorine having a log Kow of 5.41
(Hansch et al. 1995). This might be explained by the fact that
chlordecone specifically binds to liver proteins and to plasma
proteins, particularly albumin and high-density lipoproteins
(HDL); this contrast with organochlorine pesticides which
bind preferentially to VLDL and LDL lipoproteins and are
preferentially distributed to fat tissues (Soine et al. 1982;
Soine et al. 1984). Chlordecone (Kepone) is excreted in hu-
man bile as a reduced metabolite (chlordecone alcohol) and in
the form of a glucuronide conjugate (Cohn et al. 1978). The
bioreduction is catalyzed by a hepatic cytosolic enzyme
termed chlordecone reductase (Molowa et al. 1986).
However, only 5 % of the pesticide undergoing biliary excre-
tion appears in stools each day, suggesting that it may be
subject to an enterohepatic cycle process (intestinal reabsorp-
tion and recirculation to the liver) (Blanke et al. 1978).
Experimental studies with birds and mammals show effects
similar to those reported in occupationally exposed humans
including neurological effects, oligospermia, and hepatomeg-
aly (reviewed in Faroon et al. 1995). Gestational and perinatal
chlordecone exposures in rodents have been shown to be det-
rimental to normal fetal development and to impair
neurobehavior during preweaning and postweaning develop-
ment (Mactutus et al. 1982, 1984; Mactutus and Tilson 1984,
1985). Long-term feeding with chlordecone also produced an
increased incidence of liver tumors mediated by tumor pro-
motion rather than initiation (Reuber 1979; Sirica et al. 1989).
Proteinuria, never observed in highly exposed men despite
appropriate investigations (Guzelian 1982), was shown to be
the most sensitive toxic endpoint in rats (Faroon et al. 1995)
and is currently used as the basis for establishing acceptable
levels of human exposure.
A great number of mechanisms have been suggested, but
not always clearly demonstrated, to explain the toxicological
profile of chlordecone. Nevertheless, hormone-like properties
have been clearly established both in vivo and in vitro
(Hammond et al. 1979; Eroschenko 1981): chlordecone has
estrogenic properties that are now well established, and it is
considered to be an endocrine-disrupting chemical.
Health consequences of chlordecone exposure
in the French West Indies
To date, there have been no publications, reports or testimo-
nies of the presence of the Kepone shake syndrome in the
French West Indies even among the banana farmers who used
chlordecone. It is possible that their exposure was sufficiently
low level for the internal bodily concentrations to have
remained below the threshold (1 mg/L blood) for the onset
of these severe clinical effects. However, we cannot complete-
ly rule out the possibility that there have been cases of this
syndrome but that they were not recognized because of the
diversity of signs and symptoms or that their relationship with
chlordecone exposure was not recognized.
From 1999, various epidemiological studies have been ini-
tiated in the French West Indies to determine chlordecone
exposure and its health consequences for the population.
Male fertility
Chlordecone exposure affected sperm production and motility
in men exposed at the Hopewell factory and experimental
exposure has similar effects in rodents (Cohn et al. 1978;
Linder et al. 1983).
In 1998, 1 year before the rediscovery of environmental
pollution by chlordecone, a cross-sectional study was con-
ducted to assess the fertility of banana workers and of men
working in nonagricultural sectors in Guadeloupe. Blood and
semen samples were collected from 100 adult men (Multigner
et al. 2006; 2008). Further exploiting this study, the blood
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samples were later used to determine chlordecone body bur-
den. Blood chlordecone was detected (limit of detection
[LOD] ∼1 μg/L) in 88 % of men. The concentrations in ba-
nana workers (median 6.3 μg/L; range <LOD–104.5) were
slightly but significantly higher than those in men who
worked in nonagricultural sectors (median 5.5 μg/L; range
<LOD–46.6). There were no significant differences between
banana workers and workers in nonagricultural sectors for
time to pregnancy for the last conception or for any semen
characteristic (semen volume, sperm concentration, output,
motility, and morphology) or hormone level (FSH, LH,
Inhibin B, testosterone, and estradiol) (Multigner et al.
2008). Moreover, there were no significant correlations be-
tween chlordecone concentrations in blood and any semen
characteristic or hormone concentration (Multigner et al.
2006). These results showed that current exposure levels, sev-
eral years after the cessation of chlordecone use in banana
fields, does not detectably affect male fertility; they thus agree
with previous observations showing that the threshold for
abnormally low seminal characteristics was of 1 mg/L
(Cohn et al. 1978).
Pregnancy complications and outcomes
Few women were affected by the chlordecone poisoning ep-
isode in Hopewell, and no studies could be done in pregnant
women and newborns (Cannon et al. 1978). Studies on ani-
mals show that pregestational or gestational exposure of rats
and mice affects implantation and prenatal and postnatal de-
velopment (reviewed in Faroon et al. 1995).
In 2004, the blood chlordecone concentration was deter-
mined in 112 pregnant women at delivery in Guadeloupe
(Hibiscus study) (Kadhel 2008): chlordecone was detected
(LOD 0.50 μg/L) in 87 % (median 2.2 μg/L; range <LOD–
16.5). Chlordecone was also assayed in subcutaneous abdom-
inal fat from a sample (n=52) of women who delivered by
cesarean and detected in all samples (median 39.0 μg/kg
lipids; range 25.1–207.1). The fat-to-blood ratio was 14 for
chlordecone; the partition coefficient of other organochlorines
in the same samples was 107 for p,p′-DDE and 362 for
PCB153.
A prospective epidemiological mother–child cohort
(Timoun study) was subsequently established in Guadeloupe
to study the consequences of prenatal and postnatal
chlordecone exposure on pregnancy and infant development.
From 2004 to 2007, 1068 pregnant women were enrolled
during the third-trimester checkup. At enrolment, the partici-
pants answered a standardized questionnaire covering
sociodemographic characteristics, medical and obstetrical his-
tory, and lifestyle factors. After delivery, the medical history
of the pregnancy and delivery information was collected. A
semiquantitative food frequency questionnaire collected usual
dietary intake during pregnancy. Maternal exposure in this
cohort was attributed to the intake of contaminated food and
water, especially seafood, root vegetables, and cucurbitaceous
vegetables (Guldner et al. 2010). Maternal blood samples
were obtained at delivery. Blood chlordecone was detected
(LOD 0.06 μg/L) in 88 % of pregnant women (median
0.39 μg/L; range <LOD–19.3).
Hypertensive disorders and diabetes mellitus are common
problems during pregnancy and are associatedwith significant
short-term and long-term adverse health outcomes for both
mothers and children. In a case–control study within the full
Timoun cohort study, maternal chlordecone exposure was
found to be associated with a significantly lower risk of ges-
tational hypertension (odds ratio [OR] 0.2; 95 % confidence
interval (CI) 0.1, 0.5, and OR 0.3; 95 % CI 0.2, 0.7, for the
third and fourth quartiles of exposure, respectively) (Saunders
et al. 2014). No significant associations were observed be-
tween chlordecone exposure and the risk of preeclampsia or
gestational diabetes mellitus. The negative association ob-
served between exposure to chlordecone and risk of gestation-
al hypertension could be due to a hypotensive effect mediated
by the sympathomimetic and/or progestin properties of the
molecule (Hammond et al. 1979; Tilson et al. 1987).
The potential effects of maternal chlordecone exposure on
length of gestation and preterm birth (birth before 37 complet-
edweeks of gestation) have also been examined in the Timoun
cohort study (Kadhel et al. 2014). The regression coefficient
for length of gestation (β) was significantly lower for the
fourth and fifth quintiles of exposure (−0.60, 95 % CI −0.99,
−0.20, and −0.48, 95 % CI −0.88, −0.07, respectively). The
hazard ratio (HR) for preterm birth was also significantly
higher for the fourth and fifth quintiles of exposure (3.1,
95 % CI 1.6, 6.0, and 2.2, 95 % CI 1.1, 4.5, respectively). A
one log10 increase in chlordecone concentration was associat-
ed with decreased length of gestation (β −0.26 week, 95 % CI
−0.49, −0.03) and increased risk of preterm birth (HR 1.60;
95 % CI 1.1, 2.3). Parturition is triggered by the shortening
and dilatation of the cervix associated with uterine contrac-
tions. Progesterone plays a key role in maintaining pregnancy,
and treatment of pregnant women with progesterone receptor
antagonists induces labor at any stage of pregnancy (Chwalisz
and Garfield 1994). Chlordecone binds estrogen receptors
(ER) and stimulates the synthesis in vivo of the progesterone
receptor in rat uterine tissues (Hammond et al. 1979), and this
process is mediated by ER. These observations suggest that
the observed associations between exposure to chlordecone
and decreased gestational length and increased risk of preterm
birth are due to estrogenic and/or progestin activities of
chlordecone.
Early child development
Chlordecone crosses the placental barrier in pregnant rodents
and transfers to the newborn through maternal breastfeeding,
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thus exposing the developing organism during the earliest
stages of development (Kavlock et al. 1980).
In the Hibiscus study, the blood cord of 112 newborns and
colostrum of mothers who intended to breastfeed were
assayed for chlordecone (Kadhel 2008). Chlordecone was de-
tected (LOD 0.50 μg/L) in 61 % of cord blood samples
(median 0.7; range <LOD–3.7) and 39 % of colostrum
samples (range of detectable values 0.5–2.8 μg/L). The
milk-to-blood ratio was 1/10 for chlordecone; the partition
coefficient of other organochlorines in the same samples was
6 for p,p′-DDE and 7 for PCB153. The partitioning of
chlordecone is the consequence of specific transporters in
blood (see above). Indeed, chlordecone is transported by
HDL lipoproteins which promote transport to the liver and
not to peripheral fat or breast milk, the latter being free of
triglycerides and type HDL cholesterol.
In the Timoun cohort study, cord blood samples were ob-
tained at delivery and breast milk samples were collected
3 months after delivery. Chlordecone was detected (LOD
0.06 μg/L) in 56 % of the cord blood samples (median
0.25 μg/L; range <LOD–22.9) and 77 % of the breast milk
samples (median 0.10 μg/L; range <LOD–0.34). In a follow-
up of this cohort, infants were examined at 7 months of age to
evaluate their visual acuity, cognition, and motor development
using the Teller visual acuity card test II, the Fagan test of
infant intelligence, and the Brunet-Lezine scale of psychomo-
tor development (Dallaire et al. 2012). At 18 months of age,
infant development was assessed with the ages and stages
questionnaire (ASQ), a parent-completed screening test aimed
at identifying children at risk of developmental delay
(Boucher et al. 2013). Maternal interviews were conducted
at these times to assess both potential confounders pertaining
to sociodemographic and psychosocial domains, and the qual-
ity of stimulation provided by the family.
At 7 months, a dose-dependent decrease in novelty prefer-
ence with higher cord chlordecone concentrations was ob-
served (β −0.19, 95 % CI −0.35, −0.03, for the third tertile
of exposure) (Dallaire et al. 2012). The preference for novelty
tasks (longer fixations on new stimuli than on previously pre-
sented stimuli) is an indicator of short-term visual memory in
infants (Fagan and Singer 1983). This result is consistent with
reports of poorer short-term memory among workers in
Hopewell (Cannon et al. 1978). In rodent models, preweaning
rats exposed to chlordecone during the neonatal period exhib-
ited memory deficits, particularly in early learning and infor-
mation retention in passive avoidance tests (Mactutus et al.
1982; Mactutus and Tilson 1984).
Detectable levels of chlordecone in cord blood were also
associated with higher risk of low scores on the fine motor
development scale at 7 months (OR 1.26, 95 % CI 1.09, 1.47)
(Dallaire et al. 2012). At 18 months of age, high chlordecone
concentrations (as continuous value) in cord blood were still
associated with poorer fine motor scores (β −0.24, p 0.03)
(Boucher et al. 2013). This is in accordance with the observa-
tion of intention tremors in the exposed Hopewell employees
and fine body tremors in rats after neonatal exposure to
chlordecone (Cannon et al. 1978; Mactutus et al. 1984). At
18 months, analyses were also conducted separately for boys
and girls, and this effect was only observed among boys (β
−0.32, p 0.03), possibly related to chlordecone’s estrogen-like
activity.
Recently, the impact of perinatal exposure to chlordecone
on the thyroid hormone system at 3 months of age and on
subsequent neurodevelopment was explored (Cordier et al.
2015). Cord chlordecone was associated with an increase in
TSH in boys, whereas postnatal exposure (breastfeeding) was
associated with a decrease in FT3 overall, and in FT4 in girls.
Higher TSH concentrations at 3 months were positively asso-
ciated with the ASQ score for fine motor development at
18 months, but TSH did not modify the association between
prenatal chlordecone exposure and poorer ASQ fine motor
score for boys. This suggests that the developmental toxicity
of chlordecone may be mediated by the estrogen signaling
pathway rather than by, or in addition to, the thyroid endocrine
system
Prostate cancer
Chlordecone is a potential carcinogen and causes hepatic tu-
mors in laboratory rats and mice (Reuber 1979). A few hun-
dredmen were affected by the poisoning episode in Hopewell,
a number insufficient for the long-term consequences on the
incidence rare conditions, such as cancers, to be studied. The
carcinogenic and hormonal properties of chlordecone and its
long biological half-life make long-term effects, such as can-
cer, entirely plausible. In the particular context of the French
West Indies, it was assumed that populations were first ex-
posed to chlordecone in the early 1970s. Because chlordecone
is a recognized endocrine-disrupting chemical, the potential
relationship with hormone-dependent cancer was considered.
A population-based case–control study was carried out in
Guadeloupe from 2005 to 2007 to investigate the relationship
between exposure to chlordecone and the risk of prostate can-
cer, the most common cancer in this population (Mallick et al.
2005). A total of 623 men with newly diagnosed prostate
cancer and 671 controls were compared (Multigner et al.
2010). Exposure was determined from current plasma concen-
tration: chlordecone was detected (LOD 0.25μg/L) in 67% of
the subjects (median 0.6 μg/L; range <LOD–49.1). A signif-
icant positive association was found between the chlordecone
concentration in blood and prostate cancer (OR 1.77; 95 % CI
1.21, 2.58, for the highest tertile of values above the LOD).
These data were recently reanalyzed using, after validation of
quality control charts, a LOD of 0.06 μg/L, and handling
missing data by multiple imputation (Emeville et al. 2015).
The significant positive association between chlordecone
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exposure and prostate cancer risk was confirmed (OR 1.65,
95 % CI 1.09, 2.48, for the highest quintile of exposure).
Comparable results were observed when p,p′-DDE or
PCB153 concentrations were included in the full model (OR
1.64, 95 % CI 1.09, 2.47, and OR 1.70, 95 % CI 1.12, 2.56,
respectively).
Chlordecone may act as a tumor promoter, through
hormone-mediated effects. Chlordecone binds the ER α
(ERα) and β (ERβ), acting as an agonist of ERα and
an antagonist of ERβ (Kuiper et al. 1998; Lemaire et al.
2006). ERα mediates the adverse effects of estrogen on
the prostate, including aberrant proliferation, inflammation,
and malignancy. ERβ exerts opposite and beneficial ef-
fects, such as antiproliferative, anti-inflammatory, and, po-
tentially, anticarcinogenic effects (Ellem and Risbridger
2009). The interplay between the agonistic effects of
chlordecone on ERα and its antagonistic effects on ERβ
may increase proliferation of estrogen-sensitive tissues, in-
creasing the risk of cancer.
Conclusions
Chlordecone (Kepone) is now one of the environmental
chemical agents most extensively studied for its effects
on humans. More than 5 years of clinical investigations
of workers heavily exposed in US and 10 years of epide-
miological studies in the general population of the French
West Indies exposed at environmental levels have
established the spectrum of human toxicity of chlordecone.
From 1999 to date, measurement of chlordecone in blood
samples has revealed that a large proportion of the French
West Indies population is still contaminated. Although ex-
posure levels do not seem to have reached those that
trigger the onset of the Kepone shake syndrome, epidemi-
ological studies have revealed that there are effects during
critical windows of exposure (pregnancy and infant devel-
opment) and possibly long-term effects such as cancer.
Further efforts are required to protect the population
against exposure to chlordecone, particularly by reducing
its intake through the diet.
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